HK1028347A1 - Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity - Google Patents

Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity

Info

Publication number
HK1028347A1
HK1028347A1 HK00107849A HK00107849A HK1028347A1 HK 1028347 A1 HK1028347 A1 HK 1028347A1 HK 00107849 A HK00107849 A HK 00107849A HK 00107849 A HK00107849 A HK 00107849A HK 1028347 A1 HK1028347 A1 HK 1028347A1
Authority
HK
Hong Kong
Prior art keywords
antiviral
pharmaceutical
glycyrrhizic acid
composition
antiviral activity
Prior art date
Application number
HK00107849A
Other languages
English (en)
Inventor
Raffaello Pompei
Mario Pinza
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1028347A1 publication Critical patent/HK1028347A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK00107849A 1997-05-14 2000-12-07 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity HK1028347A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001119A IT1291366B1 (it) 1997-05-14 1997-05-14 Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
PCT/EP1998/002797 WO1998051334A1 (en) 1997-05-14 1998-05-06 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity

Publications (1)

Publication Number Publication Date
HK1028347A1 true HK1028347A1 (en) 2001-02-16

Family

ID=11377123

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00107849A HK1028347A1 (en) 1997-05-14 2000-12-07 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity

Country Status (27)

Country Link
US (1) US6329339B1 (de)
EP (1) EP0980254B1 (de)
JP (2) JP2001525814A (de)
KR (1) KR100592193B1 (de)
CN (1) CN1114447C (de)
AR (1) AR012849A1 (de)
AT (1) ATE212232T1 (de)
AU (1) AU740944B2 (de)
BG (1) BG64748B1 (de)
CA (1) CA2289550A1 (de)
CZ (1) CZ291932B6 (de)
DE (1) DE69803565T2 (de)
DK (1) DK0980254T3 (de)
EA (1) EA003126B1 (de)
ES (1) ES2170501T3 (de)
GE (1) GEP20022672B (de)
HK (1) HK1028347A1 (de)
HU (1) HU224956B1 (de)
IL (2) IL132651A0 (de)
IT (1) IT1291366B1 (de)
PL (1) PL189218B1 (de)
PT (1) PT980254E (de)
SK (1) SK283584B6 (de)
TR (1) TR199902730T2 (de)
UA (1) UA63955C2 (de)
WO (1) WO1998051334A1 (de)
ZA (1) ZA983917B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
EP1499341A4 (de) * 2002-04-18 2010-10-27 Univ Iowa Res Found Verfahren zur hemmung und behandlung von bakteriellen biofilmen mit metallchelatbildern
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
AU2004272607B2 (en) * 2003-09-11 2008-11-06 Cornerstone Therapeutics Inc. Monoclonal antibodies against HMGB1
EP1909834A2 (de) * 2005-07-18 2008-04-16 Critical Therapeutics, Inc. Verwendung von hmgb1-antagonisten zur behandlung von entzündungskrankheiten
EP1959997A4 (de) * 2005-11-28 2009-12-23 Medimmune Llc Antagonisten von hmgb1 und/oder rage und verwendungsverfahren dafür
IT1391170B1 (it) * 2008-08-07 2011-11-18 D M G Italia S R L Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale
WO2012026928A1 (en) * 2010-08-25 2012-03-01 Diacarta Llc Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
JP5806434B1 (ja) 2014-02-21 2015-11-10 国立大学法人東京海洋大学 ノロウィルス不活化剤及びその製造方法、ノロウィルス不活化方法、ノロウィルス不活化用リゾチーム類の製造方法、ノロウィルス感染の予防薬又は治療薬、並びにノロウィルス不活化用皮膚外用剤
CN117942405A (zh) * 2016-02-25 2024-04-30 应用生物实验室公司 保护空气传播的病原体和刺激物的组合物和方法
CN109022351B (zh) * 2018-09-28 2021-10-19 广州奇龙生物科技有限公司 重组人溶菌酶的新应用
CN112135625B (zh) * 2020-04-27 2021-07-06 广州新创忆药物临床研究有限公司 一种预防或治疗covid-19新冠肺炎的药物及其应用
EP4144363A4 (de) * 2020-04-27 2024-05-29 Guangzhou Century Clinical Research Co., Ltd Arzneimittel, nahrungsmittel und anwendung einer anti-koronavirus-infektion
US20220305092A1 (en) * 2020-04-27 2022-09-29 Guangzhou Century Clinical Research Co., Ltd Medicament and food for preventing or treating novel coronavirus pneumonia covid-19 and use thereof
MX2021005280A (es) * 2021-05-04 2022-02-23 Spv Timser S A P I De C V Composicion farmaceutica que contiene triterpenoides pentaciclicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085800B2 (ja) * 1986-12-19 1996-01-24 エーザイ株式会社 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
JP2838720B2 (ja) * 1989-10-31 1998-12-16 ゼリア新薬工業株式会社 安定な点眼剤
JP4056099B2 (ja) * 1996-05-09 2008-03-05 森永乳業株式会社 水生動物の寄生生物性疾患の予防および治療剤

Also Published As

Publication number Publication date
PT980254E (pt) 2002-07-31
TR199902730T2 (xx) 2000-02-21
KR100592193B1 (ko) 2006-06-23
US6329339B1 (en) 2001-12-11
BG103968A (en) 2000-07-31
JP2001525814A (ja) 2001-12-11
DE69803565D1 (de) 2002-03-14
ES2170501T3 (es) 2002-08-01
ITMI971119A1 (it) 1998-11-14
HU224956B1 (en) 2006-04-28
AU7764698A (en) 1998-12-08
CZ399199A3 (cs) 2000-04-12
IL132651A0 (en) 2001-03-19
SK154499A3 (en) 2000-08-14
SK283584B6 (sk) 2003-10-07
EA199901024A1 (ru) 2000-06-26
HUP0002985A3 (en) 2001-04-28
JP2009102370A (ja) 2009-05-14
KR20010012419A (ko) 2001-02-15
HUP0002985A2 (hu) 2001-01-29
EP0980254B1 (de) 2002-01-23
DE69803565T2 (de) 2002-08-08
WO1998051334A1 (en) 1998-11-19
ATE212232T1 (de) 2002-02-15
GEP20022672B (en) 2002-04-25
PL336802A1 (en) 2000-07-17
IL132651A (en) 2006-10-31
AU740944B2 (en) 2001-11-15
CZ291932B6 (cs) 2003-06-18
CN1114447C (zh) 2003-07-16
AR012849A1 (es) 2000-11-22
IT1291366B1 (it) 1999-01-07
CA2289550A1 (en) 1998-11-19
CN1255859A (zh) 2000-06-07
ITMI971119A0 (de) 1997-05-14
BG64748B1 (bg) 2006-02-28
PL189218B1 (pl) 2005-07-29
EA003126B1 (ru) 2003-02-27
UA63955C2 (uk) 2004-02-16
DK0980254T3 (da) 2002-05-06
ZA983917B (en) 1998-11-09
EP0980254A1 (de) 2000-02-23

Similar Documents

Publication Publication Date Title
HK1028347A1 (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
DE69828512D1 (de) Granulierter plasmaproteinfutterzusatz mit erhöhter biowirksamkeit
EP0950665A4 (de) Veränderte physiologisch aktive proteine und medizinische verbindungen, die diese beinhalten
ZA985352B (en) Barbituric acid derivatives with antimetastatic and antitumor activity.
IL128144A0 (en) Benzamidine derivatives and their use as medicaments with an ltb4-antagonistic activity
HUP0105105A3 (en) Macrolides with anti-inflammatory activity and medicaments containing them
IL126247A0 (en) Novel imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them
AU8016398A (en) Peptides with antiviral activity
ZA9811655B (en) Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same
HUP0003189A2 (en) Pharmaceutical composition comprising fexofenadine and its derivatives
ZA986756B (en) Modified polypeptides with high activity and reduced allergenicity
DE69833460D1 (de) Rekombinantes allergen mit reduzierter enzymatischer aktivität
PL338856A1 (en) Dried biologically or therapeutically active preparations
AU8168898A (en) Interferon stimulating protein and uses thereof
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
SI0980254T1 (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
AU1821300A (en) Peptides having anti-cancer and anti-inflammatory activity
EP0692537A3 (de) Rekombinante Gibberellin-DNA und deren Verwendung
NZ325260A (en) Covalent-lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments
HUP9901165A3 (en) Thiamorphinans with neuroprotective activity, pharmaceutical compositions and use of the same
KR0185794B1 (en) Pharmaceutical preparations having anti-fibrotic activity
ZA977043B (en) Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
GB9725149D0 (en) Insecticidal gene and peptide
GB9702189D0 (en) Insecticidal gene and peptide
GB9714100D0 (en) Further anthraquinones with biological activity

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090506